NO974486D0 - Low-dose "Ridogrel" formulations and their use in the treatment of intestinal inflammation - Google Patents

Low-dose "Ridogrel" formulations and their use in the treatment of intestinal inflammation

Info

Publication number
NO974486D0
NO974486D0 NO974486A NO974486A NO974486D0 NO 974486 D0 NO974486 D0 NO 974486D0 NO 974486 A NO974486 A NO 974486A NO 974486 A NO974486 A NO 974486A NO 974486 D0 NO974486 D0 NO 974486D0
Authority
NO
Norway
Prior art keywords
ridogrel
formulations
dose
treatment
low
Prior art date
Application number
NO974486A
Other languages
Norwegian (no)
Other versions
NO974486L (en
Inventor
Maria-Helena Joris J Verlinden
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO974486D0 publication Critical patent/NO974486D0/en
Publication of NO974486L publication Critical patent/NO974486L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
NO974486A 1995-03-28 1997-09-29 Low-dose "Ridogrel" formulations and their use in the treatment of intestinal inflammation NO974486L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95200768 1995-03-28
PCT/EP1996/001229 WO1996030016A2 (en) 1995-03-28 1996-03-18 Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases

Publications (2)

Publication Number Publication Date
NO974486D0 true NO974486D0 (en) 1997-09-29
NO974486L NO974486L (en) 1997-09-29

Family

ID=8220134

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974486A NO974486L (en) 1995-03-28 1997-09-29 Low-dose "Ridogrel" formulations and their use in the treatment of intestinal inflammation

Country Status (10)

Country Link
EP (1) EP0817631A2 (en)
JP (1) JPH10511097A (en)
AR (1) AR002727A1 (en)
AU (1) AU5397496A (en)
CA (1) CA2215160A1 (en)
HU (1) HUP9900309A3 (en)
IL (1) IL117670A (en)
NO (1) NO974486L (en)
WO (1) WO1996030016A2 (en)
ZA (1) ZA962461B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9620709D0 (en) * 1996-10-04 1996-11-20 Danbiosyst Uk Colonic delivery of weak acid drugs
WO2002072069A1 (en) * 2001-03-12 2002-09-19 Novo Nordisk A/S Novel tablets and capsules and a process for its preparation
ITRM20050389A1 (en) 2005-07-22 2007-01-23 Giuliani Spa COMPOUNDS AND THEIR SPECIFIC SALTS FOR PPAR RECEPTORS AND RECEPTORS FOR EGF AND THEIR USE IN MEDICAL FIELDS.
UA107562C2 (en) 2008-12-05 2015-01-26 METHOD OF TREATMENT OF PSORIASIS
US8754127B2 (en) 2009-02-16 2014-06-17 Nogra Pharma Limited Alkylamido compounds and uses thereof
JP6301844B2 (en) 2012-02-09 2018-03-28 ノグラ ファーマ リミテッド How to treat fibrosis
BR112014026160A2 (en) 2012-04-18 2017-07-18 Nogra Pharma Ltd Methods To Treat Lactose Intolerance
WO2017046343A1 (en) * 2015-09-17 2017-03-23 Nogra Pharma Limited Compositions for rectal administration in the treatment of ulcerative colitis and methods of using same
EA202192207A1 (en) 2019-02-08 2021-10-27 Ногра Фарма Лимитед METHOD FOR OBTAINING 3- (4'-AMINOPHENYL) -2-METHOXYPROPIONIC ACID AND ITS ANALOGUES AND INTERMEDIATE COMPOUNDS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746671A (en) * 1985-11-04 1988-05-24 Janssen Pharmaceutica N.V. Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoic acids and esters

Also Published As

Publication number Publication date
AU5397496A (en) 1996-10-16
IL117670A (en) 2000-02-29
WO1996030016A2 (en) 1996-10-03
CA2215160A1 (en) 1996-10-03
JPH10511097A (en) 1998-10-27
HUP9900309A2 (en) 1999-05-28
MX9707394A (en) 1997-11-29
HUP9900309A3 (en) 1999-11-29
IL117670A0 (en) 1996-07-23
NO974486L (en) 1997-09-29
EP0817631A2 (en) 1998-01-14
AR002727A1 (en) 1998-04-29
ZA962461B (en) 1997-09-29
WO1996030016A3 (en) 1997-01-30

Similar Documents

Publication Publication Date Title
IL117993A0 (en) Modified anti-icam-1 antibodies and their use in the treatment of inflammation
GR980300033T1 (en) Compositions for the treatment of dermatological disorders and methods for their use
AU4054297A (en) Manipulations of nitrosative and oxidatives stress in the treatment of disease
AU7230196A (en) Pskh-1 ribozymes and uses in disease treatment
IL114586A (en) Droloxifene for use in the treatment of cardiovascular diseases and pharmaceutical compositions comprising same
ZA899176B (en) Use of acetyl d-carnitine in the therapeutic treatment of glaucoma and pharmaceutical compositions useful in such treatment
AU4700297A (en) Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans
AU7397094A (en) Prevention and treatment of alzheimer's disease
ITRM940328A0 (en) "USE OF PRODUCTS CONTAINING MAGNESIUM IN THE THERAPY AND PROPHYLAXIS OF NEOPLASTIC DISEASES AND AUTOIMMUNE TYPE DISEASES".-
NO974486D0 (en) Low-dose "Ridogrel" formulations and their use in the treatment of intestinal inflammation
GB9419553D0 (en) Polypeptides and their use in the treatment of auto-immune disease
GB9321341D0 (en) Therapeutic compositions for use in the treatment of skin lesions and method of making same
HUP0003244A3 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases and pharmaceutical compositions thereof
AU2135095A (en) Linoleoylamide based ceramide derivative and its use in cosmetic preparations for the treatment of dry skin
HUP9800829A3 (en) Collagen-based methods and formulations for the treatment of immune system-mediated diseases
FR2685867B1 (en) COMPOSITIONS AGAINST DEQUAMATION OF THE SKIN AND SCALP.
AU7622798A (en) Application of thalidomide to the treatment of Parkinson's disease and Parkisonian syndromes
EP0833641A4 (en) Treatment and prevention of prostatic disease
HUP9701606A3 (en) Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of certain psychomotor and psychointellectual disorders
AU2705495A (en) Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory
HUP9602557A2 (en) Use of natural cyclodextrines and their derivatives for solubilizing materials of trombocite-aggregation-inhibiting activity in the ginkgolide's family
GB2279567B (en) Compositions for the treatment of inflammatory proliferative skin disease and their use
LV5177A3 (en) Preparation "eridone" for the prevention and treatment of endometritis in cows
FR2758980B1 (en) LOCAL AND GENERAL BODY TREATMENT HYDROTHERAPY APPARATUS
GB9516572D0 (en) Prevention and/or treatment of disease